Pharmacies face audit risks in their everyday operations, and staying ahead to protect claims from audit recoupments can be exhausting. PAAS National®® analysts continue … Interested in a customized FWA/HIPAA Compliance Policy and Procedure program? Contact PAAS National®® at info@paasnational.com or (608) 873-1342 to get started today!
Last month we wrote an article entitled: Guidelines for Dispensing Insulin Pens in their Original Carton. A few days later, the Office of Inspector General (OIG) announced that CVS had agreed to a $37.76 million settlement for violations of the False Claims Act by over-dispensing insulin pens between 2010 and 2020. Investigators found that Medicare, […]
Keeping up with all the new insulin products has become a full-time job. The range of delivery devices and concentrations continues to expand. Pharmacies need to stay informed about these updates to ensure their prescriptions meet audit requirements. Recently, PBMs have flagged insulin prescriptions as …
Pharmacies serve a vital role in supporting their communities, especially when patients face disruptions during natural disasters. In such events, access to essential medication can be compromised. While helping patients through these challenging times, ensure that your pharmacy’s claims remain protected by confirming staff understand which override(s) to use and how to apply them correctly.
Transferring prescriptions into your pharmacy is usually great for business; however, pharmacies must be aware of the additional audit risks with these prescriptions. PBM audit algorithms easily identify transfers due to the origin code of 5 being submitted during claim adjudication. Each state has requirements put in place by their pharmacy board that outline what […]
While the COVID-19 Public Health Emergency officially ended on May 11, 2023, the 12th Amendment of the Public Readiness and Emergency Preparedness Act (PREP) was extended until December 31, 2029. This allows pharmacies to continue dispensing OTC COVID-19 tests to patients without a prescription. Many state Medicaid and commercial insurance plans continue to cover this […]
PAAS National®® analysts continue to see pharmacies fall victim to Caremark’s Aberrant Practices and Trends enforcement.
GLP-1 medications continue to come under scrutiny from PBM auditors for several reasons. High cost, off-label use, rising utilization, and billing irregularities make these easy audit targets. Pharmacies must remain diligent to ensure accuracy and appropriateness when dispensing these medications to avoid recoupments. The latest in audit recoupments have come from…
Traditional dispensing for independent pharmacies continues to transform. Beyond dispensing prescriptions at the pharmacy counter, some pharmacies are providing patient-specific prescriptions directly to clinics for administration. Pharmacies must be aware and protect themselves from the heightened audit risks. While PAAS National®® has written countless Newsline articles on signature, delivery, and mailing requirements to help our […]
Migraine medications continue to be targeted for audit by all PBMs. With new products on the market, rising costs, and frequency of refills, PBMs are looking for billing errors to claw back payments on audit. OptumRx’s latest tactic…
